Navigation Links
Battelle Selects Xie to Develop Biomarker Services

COLUMBUS, Ohio, June 25 /PRNewswire-USNewswire/ -- Battelle is strengthening its customer-focused biomarker services portfolio to pharmaceutical, biotechnology, medical device, and government clients, and Kevin Xie will lead those efforts as Battelle's Vice President of Biomarker Services.

Battelle offers a suite of biomarker services, including biomarker discovery, qualification, and validation services to help our clients better define molecular mechanisms of diseases, toxicity, and therapeutic responses.

Xie brings an impressive background to Battelle. He has expertise in pharmaceutical, medical device and diagnostics spanning a number of therapeutic areas including oncology, immunology and infectious diseases.

He has been the director and head of global business development of specialty pharmaceuticals at Boehringer Ingelheim Corp. for the last two years. For four years prior to that, Xie was the director and head of global business development for diabetes care for Bayer Healthcare. At Vertex Pharmaceuticals from 2000-02, he was the director of licensing and business development. For the three years prior to that, Xie was the director of business development and strategic planning at Baxter Healthcare.

Xie earned a Ph.D. in molecular biology at Yale University as well as an MBA in finance and strategy. He earned bachelor's and master's degrees from Fudan University in Shanghai, China.

"We are pleased to hire Kevin not only because we believe he is a quality person but because his diverse background made him the perfect candidate for the job," said Barbara Kunz, President of Battelle's Health and Life Sciences Global Business. "The mix of business, biology, and pharmacological work in his career will make him successful here."

Battelle's Global Health and Life Sciences Global Business delivers a comprehensive set of R&D services to solve complex challenges for government health agencies and medical device, biotechnology, and pharmaceutical firms. Including its national laboratories, Battelle oversees over $200 million annually in health and life sciences research and development contributing to advances in medical devices, pharmaceuticals, public health, and next-generation diagnostics and therapeutics.

Battelle is the world's largest non-profit independent research and development organization, providing innovative solutions to the world's most pressing needs through its four global businesses: Laboratory Management, National Security, Energy Technology, and Health and Life Sciences. It advances scientific discovery and application by conducting $4 billion in global R&D annually through contract research, laboratory management, and technology commercialization. Headquartered in Columbus, Ohio, Battelle oversees 20,400 employees in more than 120 locations worldwide, including seven national laboratories which Battelle manages or co-manages for the U.S. Department of Energy and the U.S. Department of Homeland Security.

Battelle also is one of the nation's leading charitable trusts focusing on societal and economic impact and actively supporting and promoting science and math education.

Contact National Media Relations Manager Katy Delaney at (410) 306-8638 or or T.R. Massey, Media Relations Specialist, at (614) 424-5544 or for more information.

SOURCE Battelle
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Ventaira Pharmaceuticals Announces Acquisition of Assets by Battelle
2. MEDRAD, Battelle Win Medical Design Excellence Award for MEDRAD XDS(TM) Extravasation Detector
3. Battelle Collaborating With Korean Partners to Advance Energy Efficiency and Health and Life Sciences Initiatives in Korea
4. Battelle Earns 2008 Presidential Green Chemistry Award
5. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
6. Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software
7. E-Rad Solutions Selects Compressus Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. GeneSeek Selects the British Midlands as Base for New UK/European Operations
10. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
11. GSA Selects Cascades Technologies, Inc. (CTi) to Support
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ... Accutest Research Laboratories, a leading independent ... (CRO), has formed a strategic partnership ... Temple Health for joint work on ... ) , --> ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE ... has adopted a stockholder rights plan (Rights Plan) in ... operating loss carryforwards (NOLs) under Section 382 of the ... --> PharmAthene,s use of its NOLs could ... change" as defined in Section 382 of the Code. ...
(Date:11/25/2015)... Mass. , Nov. 25, 2015 Harvard ... biotechnology company developing bioengineered organ implants for life-threatening conditions, ... present at the LD Micro "Main Event" investor conference ... The presentation will be webcast live and posted for ... be available at the conference for one-on-one meetings on ...
(Date:11/25/2015)... ... November 25, 2015 , ... A long-standing partnership between the ... has been formalized with the signing of a Memorandum of Understanding. , AMA ... Capt. Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA ...
Breaking Biology Technology:
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... today announced broader entry into the automotive market with ... match the pace of consumer electronics human interface innovation. ... are ideal for the automotive industry and will be ... Europe , Japan ...
(Date:10/29/2015)... MINNETONKA, Minn. , Oct. 29, 2015   ... that supports the entire spectrum of clinical research, is ... the Minnesota High Tech Association (MHTA) as one of ... in the "Software – Small and Growing" category. The ... and individuals who have shown superior technology innovation and ...
Breaking Biology News(10 mins):